Alzheimer’s disease is a progressive and degenerative disorder that affects an individual’s brain and cognitive functions. It is a type of dementia, a general term for the deterioration of cognitive functions that affects memory, thinking, behavior, and the ability to perform everyday activities.
Understanding the Symptoms of Alzheimer’s Disease Read More »
Accelerated Approval is based on Phase 2 data showing a reduction in amyloid-beta plaques in early AD patients treated with LEQEMBI™ Treatment with LEQEMBI should be initiated in patients with mild cognitive impairment or mild dementia stage of disease, the population in which treatment was initiated in clinical trials TOKYO and CAMBRIDGE, Mass., Jan. 6,
Multiple Sclerosis is a long-term illness where the body’s immune system attacks and damages the protective covering, called myelin, around the nerves in the central nervous system. People with relapsing MS will have repeated attacks, known as relapses, and we’re finding new ways to stop them. People with MS can experience a variety of symptoms,
WE’RE FINDING NEW WAYS TO TREAT MULTIPLE SCLEROSIS Read More »
Alzheimer’s disease is the most frequent cause of dementia in Western societies. In the US, approximately 6.5 million people are affected, and the prevalence worldwide is estimated to be as high as 50 million. As the population continues to age, the number of individuals at risk will also increase. Alzheimer’s disease is the leading cause
THERE IS HOPE IN TREATING ALZHEIMER’S DISEASE AND ONE DAY, FINDING A CURE Read More »
A clinical research trial is led by an experienced medical staff that tests a study drug or medical device in volunteers who are participating in a study. These tests are used to see if the study drug or device is safe and effective for people to use. Each clinical trial follows a protocol, which sets
WHAT ARE THE BENEFITS OF CLINICAL RESEARCH TRIALS AND WHY DO WE NEED THEM? Read More »
Multiple Sclerosis is a long-term illness where the body’s immune system attacks and damages the protective covering, called myelin, around the nerves in the central nervous system. People with relapsing MS will have repeated attacks, known as relapses, and we’re finding new ways to stop them. People with MS can experience a variety of symptoms,
Copyright © 2025 Bradenton Research Center | Website Designed by Rohring Results
